Advice
in the absence of a submission from the holder of the marketing authorisation:
progesterone vaginal capsules (Utrogestan®) are not recommended for use within NHSScotland.
Indication under review: Prevention of preterm birth in women with a singleton pregnancy who have a short cervix (mid-trimester sonographic cervix ≤25 mm) and/or a history of spontaneous preterm birth.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice622KB (PDF)
Medicine details
- Medicine name:
- progesterone vaginal capsules (Utrogestan®)
- SMC ID:
- SMC2630
- Indication:
Prevention of preterm birth in women with a singleton pregnancy who have a short cervix (mid-trimester sonographic cervix ≤25 mm) and/or a history of spontaneous preterm birth.
- Pharmaceutical company
- Besins Healthcare (UK) Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 November 2023